Sequences

Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

Patents

3,061 publications in 1,851 families match these filters.

  1. JP 2002543145-A2002-12-17

    Metabolism intervention using GLP-1 or its biologically-active analog for improving brain function in ischemia and reperfusion injury

    BIONEBRASKA INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  2. JP 2003502344-A2003-01-21

    GLP-1 as diagnostic and examination reagent for judging beta-cell function and the presence of IGT diseases and type II diabetes

    BIONEBRASKA INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  3. US 6514500-A2003-02-04

    Long lasting synthetic glucagon like peptide {GLP-!}

    Conjuchem, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  4. JP 2003508350-A2003-03-04

    PROTECTION OF ENDOGENOUS THERAPEUTIC PEPTIDES FROM PEPTIDASE ACTIVITY THROUGH CONJUGATION TO BLOOD COMPONENTS

    Conjuchem Inc,Dominique P Bridon,ALAN M EZRIN,PETER G MILNER, Darren L Holmes,Karen Thibaudeau

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  5. US 6528486-A2003-03-04

    Peptide agonists of GLP-1 activity

    Zealand Pharma A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  6. EP 1306092-A22003-05-02

    Use of glp-1 and analogs administered peripherally, in regulation of obesity

    Eli Lilly & Company (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  7. GLP-1 FUSION PROTEINS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  8. US 6579851-A2003-06-17

    Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility

    Amylin Pharmaceuticals, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  9. US 6583111-A2003-06-24

    Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  10. JP 2003520571-A2003-07-08

    Pectate lyase fusion for expression and secretion of polypeptides.

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 348 to 378. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit   348 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 378
    

    31 of 31 identical, no gaps.

  11. JP 2003525908-A2003-09-02

    Lowering serum lipids

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  12. Expression Technology for Proteins Containing a Hybrid Isotype Antibody Moiety

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  13. JP 2003526671-A2003-09-09

    Effects of a Glucagon-Like Peptide-1 (7-36) Amide on Antro-Pyloro Duodenal Motility

    Burkhard GOKE,Jorg SCHIRRA

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  14. WO 03078462-A22003-09-25

    Glucose-dependent insulin-secreting cells transfected with a nucleotide sequence encoding glp-1

    CEDARS-SINAI MEDICAL CENTER (US)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  15. REDUCING THE IMMUNOGENICITY OF FUSION PROTEINS

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  16. EP 1359159-A22003-11-05

    Analogues of GLP-1

    SOD CONSEILS RECH APPLIC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  17. JP 2003534289-A2003-11-18

    TREATMENT OF ACUTE CORONARY SYNDROME WITH GLP-1

    Bionebraska Inc,Thomas R Coolidge,Mario Ehlers

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  18. WO 2003106663-A2003-12-24

    PRIMARY CULTURED ADIPOCYTES FOR GENE THERAPY

    EISAI CO LTD

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 18 to 48. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit   18 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 48
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  19. Glucagon-Like Peptide-1 Analogs

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  20. EP 1396499-A22004-03-10

    Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds

    ELI LILLY AND COMPANY (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  21. US 6706689-A2004-03-16

    Treatment of acute coronary syndrome with GLP-1

    Amylin Pharmaceuticals, Inc.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  22. JP 2004509079-A2004-03-25

    MODIFIED BIOLOGICAL PEPTIDES WITH INCREASED POTENCY

    THERATECHNOLOGIES INC

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  23. Peptides Acting as Both GLP-1 Receptor Agonists and Glucagon Receptor Antagonists and Their Pharmacological Methods of Use

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  24. JP 2004099621-A2004-04-02

    Prolonged Delivery of Peptides

    Scios Inc

    Query Match 100.0%Identity 100.0%Family of 3

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  25. ANALOGUES OF GLP-1

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  26. US 6747006-A2004-06-08

    Use of GLP-1 or analogs in treatment of myocardial infarction

    Eli Lilly and Company

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  27. Modification of feeding behaviour and weight control by oxyntomodulin

    IMPERIAL COLLEGE INNOVATIONS LIMITED (GB)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  28. JP 2004525630-A2004-08-26

    Expression Technology for Proteins Containing a Hybrid Isotype Antibody Moiety

    Merck Patent GmbH

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  29. EP 1454629-A22004-09-08

    Insulinotrophic agent based on preproglucagon

    AJINOMOTO CO., INC. (JP)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  30. WO 2004078195-A2004-09-16

    Inducing agent for converting intestinal cells to insulin-producing cells and antidiabetic drug

    Ajinomoto Co Inc

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  31. JP 2004532020-A2004-10-21

    Reducing the Immunogenicity of Fusion Proteins

    Lexigen Pharmaceuticals Corp

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. US 6821949-A2004-11-23

    Long lasting synthetic glucagon-like peptide (GLP-1)

    ConjuChem, Inc.

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  33. JP 2004535442-A2004-11-25

    Stable formulation of modified GLP-1

    Novo Nordisk A/S

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  34. Stable analogs of peptide and polypeptide therapeutics

    Trustees of Tufts College (US)

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  35. PRIMARY CULTURED ADIPOCYTES FOR GENE THERAPY

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 18 to 48. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit   18 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 48
    

    31 of 31 identical, no gaps.

  36. Glp-1 analog fusion plroteins

    Eli Lilly and Company (US)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  37. US 6849708-A2005-02-01

    Insulinotropic hormone and uses thereof

    The General Hospital Corporation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

  38. Separation of polypeptides comprising a racemized amino acid

    Novo Nordisk A/S (DK)

    Query Match 100.0%Identity 100.0%Family of 4

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  39. Purification of glucagon-like peptides

    Novo Nordisk A/S (DK)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  40. US 6864069-A2005-03-08

    Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use

    Bayer Pharmaceuticals Corporation

    Query Match 100.0%Identity 100.0%Family of 6

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 6

    Grouped by the same title and applicant. No priority claim is on record.

  41. Albumin-binding derivatives of therapeutic peptides

    Novo Nordisk A/S (DK)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  42. Novel plasma protein affinity tags

    Novo Nordisk A/S (DK)

    Query Match 100.0%Identity 100.0%Family of 2

    Best alignment and family

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  43. WO 2005030956-A2005-04-07

    Method for cleavage of polypeptide using OmpT protease variant

    Daiichi Suntory Pharma Co LTD

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 154 to 184. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit   154 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 184
    

    31 of 31 identical, no gaps.

  44. ANALOGUES OF GLP-1

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  45. JP 2005509409-A2005-04-14

    Methods of Treating Diabetes and Other Blood Sugar Disorders

    Genzyme Corporation

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  46. Splice variants of preproglucagon, glucagon-like peptide-1 and oxyntomodulin

    Compugen Ltd. (IL)

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 7 to 37. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 37
    

    31 of 31 identical, no gaps.

  47. US 6884579-A2005-04-26

    GLP-1 as a diagnostic test to determine .beta.-cell function and the presence of the condition of IGT and type-II diabetes

    Amylin Pharmaceuticals, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  48. US 6894024-A2005-05-17

    Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide

    Amylin Pharmaceuticals, Inc.

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
    

    31 of 31 identical, no gaps.

  49. JP 2005514060-A2005-05-19

    Albumin Fusion Proteins

    Human Genome Sciences Inc,Delta Biotechnology Limited, Principia Pharmaceutical Corporation

    Query Match 100.0%Identity 100.0%Family of 9

    Best alignment and family

    Query 1 to 31, hit 98 to 128. Positions start at 1 and include both ends.

    Query   1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
              |||||||||||||||||||||||||||||||
    Hit    98 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 128
    

    31 of 31 identical, no gaps.

    Family of 9

    Grouped by a shared priority claim, US 60/341811.

  50. JP 2005515167-A2005-05-26

    A Method of Producing Glucagon-like Peptide 1 (GLP-1) 7-36 And An GLP-1 Analogue

    SHANGHAI HUA-YI BIO-TECH LAB

    Query Match 100.0%Identity 100.0%

    Best alignment

    Query 1 to 31, hit 2 to 32. Positions start at 1 and include both ends.

    Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
             |||||||||||||||||||||||||||||||
    Hit    2 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 32
    

    31 of 31 identical, no gaps.